Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists.

No abstract is available for this paper.

• Publication year

  1955

• Venue

  A.M.A. archives of pathology

• Publication date

  1955-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 13227717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Response of patients with advanced neoplasms to the intravenous administration of alpha-peltatin.

  1954cited by this paper
• Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms

  1952cited by this paper
• Pathogenesis of the cirrhosis produced by choline deficiency; escape of lipid from fatty hepatic cysts into the biliary and vascular systems.

  1951cited by this paper
• Acute Leukaemia Treated with A-Methopterin

  1951cited by this paper
• Effect of Aminopterin on Choline, Betaine Aldehyde, and Betaine Metabolism.∗

  1951cited by this paper
• The influence of folic acid on methionine metabolism.

  1951cited by this paper
• The effects of the folic acid antagonists and 2,6‐diaminopurine on neoplastic disease. With special reference to acute leukemia

  1951cited by this paper
• A comparative study of the serum glycoproteins in patients with parenchymatous hepatic disease or metastatic neoplasia

  1951cited by this paper
• Steroid excretion in patients receiving antifolic acid compounds

  1950cited by this paper
• The response of acute leukemia to the administration of the folic acid antagonists, aminopterin and a-methopterin; report of 14 cases.

  1950cited by this paper
• The urinary excretion of 17-ketosteroids and corticosteroids in leukemia; the effects of aminopterin (4-amino-pteroylglutamic acid) on the excretion of corticosteroids in acute leukemia.

  1950cited by this paper
• Aminopterin in treatment of leukemia in children; serial aspirations of bone marrow as a guide to management and appraisal of treatment.

  1950cited by this paper
• Effect of alpha-peltatin, beta-peltatin, podophyllotoxin on lymphomas and other transplanted tumors.

  1950cited by this paper
• Bone‐marrow changes in man after treatment with aminopterin, amethopterin, and aminoanfol. With special reference to megaloblastosis and tumor remission

  1949cited by this paper
• Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.

  1948cited by this paper
• Effect of antifolic acid derivatives on patients with far-advanced carcinomatosis.

  1948cited by this paper

• Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis

  2021cites this paper
• Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta‐analysis

  2021cites this paper
• Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

  2019cites this paper
• Acute Liver Failure

  2019cites this paper
• Assessment of some side effects of methotrexate

  2018cites this paper
• Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.

  2017cites this paper
• Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.

  2017cites this paper
• Autoimmune Hepatitis-Induced Cirrhosis due to Long-Term Methotrexate Therapy for Rheumatoid Arthritis

  2016cites this paper
• EFFECTIVE ALLEVIATION OF METHOTREXATE INDUCED HEPATOTOXICITY BY

  2016cites this paper
• Preventive role of Curcumin against hepatotoxic effects of Methotrexate and Cyclophosphamide

  2016cites this paper
• Late Gastrointestinal and Hepatic Effects

  2015cites this paper
• Pathomorphological, Biochemical and Molecular Evaluation of Methotrexate Induced Hepato-Toxicity and its Amelioration by Tinospora Cordifolia

  2014cites this paper
• History of Methotrexate and Use in Psoriasis

  2012cites this paper
• Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

  2011cites this paper
• Methotrexate use and alcohol.

  2010cites this paper
• Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.

  2009cites this paper
• Congenital leukaemia with cirrhosis of liver; case and survey.

  2009cites this paper
• Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.

  2009cites this paper
• Cirrhosis-like radiological pattern in patients with breast cancer

  2008cites this paper
• Erythrocyte concentrations of metabolites or cumulative doses of 6‐mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia

  2006cites this paper
• Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis

  2006cites this paper
• A systematic review of oral methotrexate for multiple sclerosis

  2006cites this paper
• Hepatotoxicity of chemotherapy.

  2006cites this paper
• Die Therapie der Leukämien im Kindesalter

  2005cites this paper
• Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings

  2005cites this paper
• Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy

  2004cites this paper
• Methotrexate for multiple sclerosis.

  2004cites this paper
• A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy

  2004cites this paper
• Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters.

  2003cites this paper
• Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings.

  2003cites this paper
• Hepatotoxicity of chemotherapy

  2002cites this paper
• Hepatotoxicity of chemotherapy.

  2001cites this paper
• Methotrexate hepatotoxicity.

  1997cites this paper
• Methotrexate use in psoriasis and psoriatic arthritis.

  1997cites this paper
• Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia.

  1997cites this paper
• Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.

  1996cites this paper
• Is there a link between viral hepatitis and lymphoproliferative disorders? From the autopsy room to the PCR thermal cycler

  1996cites this paper
• Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term, weekly methotrexate therapy.

  1996cites this paper
• Methotrexate hepatotoxicity and the role or routine liver biopsy: A collective opinion

  1995cites this paper
• The histopathological features of chronic hepatitis C in children

  1995cites this paper
• Hepatotoxicity of chemotherapeutic and oncologic agents.

  1995cites this paper
• Methotrexate: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Rheumatoid Arthritis and Other Immunoregulatory Disorders

  1994cites this paper
• Histologic activity of the liver in children with transfusion-associated chronic hepatitis C.

  1994cites this paper
• Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?

  1994cites this paper
• Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis.

  1993cites this paper
• Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.

  1992cites this paper
• Chemotherapeutic agents and hepatotoxicity.

  1992cites this paper
• Leukemia and Liver Disease in Childhood: Clinical and Histological Evaluation

  1991cites this paper
• Low‐dose methotrexate therapy and hepatotoxicity The view of the hepatologist

  1991cites this paper
• Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis.

  1990cites this paper
• Hepatic fibrosis in juvenile chronic granulocytic leukemia: an unusual finding in three cases.

  1990cites this paper
• Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis.

  1989cites this paper
• Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.

  1989cites this paper
• Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.

  1989cites this paper
• Methotrexate-induced liver abnormalities in rheumatoid arthritis.

  1989cites this paper
• Hepatotoxicity of Methotrexate in Rheumatic Diseases

  1988cites this paper
• Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusions

  1988cites this paper
• Methotrexate-induced chronic liver injury: guidelines for detection and prevention. The ACG Committee on FDA-related matters. American College of Gastroenterology.

  1988cites this paper
• Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity

  1987cites this paper
• Hepatic Collagen Production in the Rat Is Unaffected by Methotrexate 1

  1986cites this paper
• Hepatotoxic effects of oncotherapeutic agents.

  1986cites this paper
• Adverse prognostic influence of hepatitis b virus infection in acute lymphoblastic leukemia

  1986cites this paper
• Acute hepatotoxicity induced by hepatotoxins in Suncus murinus.

  1986cites this paper
• Dermatologic Uses of Methotrexate in Children: Indications and Guidelines

  1985cites this paper
• Methotrexate and the liver.

  1985cites this paper
• The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ.

  1984cites this paper
• Primary hepatic tumors of childhood.

  1983cites this paper
• Hepatic and pancreatic damage produced by cytotoxic drugs.

  1983cites this paper
• In situ methotrexate polyglutamate formation in rat tissues.

  1983cites this paper
• Liver Assessment in Women Receiving Adjuvant CMF Chemotherapy 1

  1981cites this paper
• Ro 10-9359 in Psoriasis: Prospective Liver Biopsy Study of Potential Hepatotoxicity

  1981cites this paper
• [Primary carcinoma of the liver following lymphoblastic leukemia in childhood (author's transl)].

  1980cites this paper
• Leberzellkarzinom nach ALL im Kindesalter

  1980cites this paper
• Liver Biopsies in Psoriatics Complications and Evaluation

  1980cites this paper
• On Foreign Education

  1980cites this paper
• Drug-induced liver reactions: a morphological approach.

  1980cites this paper
• [Liver cell carcinoma following juvenile acute lymphoblastic leukemia. Case contribution].

  1980cites this paper
• [Hepatic tolerance of methotrexate].

  1979cites this paper
• Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breast.

  1979cites this paper
• Akute Leukämie (aL)

  1978cites this paper
• THE PLACE OF NEEDLE LIVER BIOPSY IN MEDICINE WITH SPECIAL Reference TO DERMATOLOGY *

  1978cites this paper
• Histopathological effects of methotrexate on mouse liver.

  1978cites this paper
• Methotrexate hepatotoxicity in children with leukemia.

  1977cites this paper
• Hepatoma in a child with methotrexate-induced hepatic fibrosis.

  1977cites this paper
• Intestinal lesions induced experimentally by methotrexate.

  1977cites this paper
• Hepatotoxicity in Wistar rats following chronic methotrexate administration: a model of human reaction.

  1977cites this paper
• Chronic toxicity of methotrexate in rats: partial to complete projection of the liver by choline: Brief communication.

  1977cites this paper
• Unusual obliterative disease of the hepatic veins in an infant

  1977cites this paper
• Toxicity of Chemotherapeutic Agents

  1977cites this paper
• Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.

  1976cites this paper
• Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.

  1976cites this paper
• Methotrexate effects on enteric mucosa liver and pancreas of normal and bled rats.

  1975cites this paper
• [Liver lesions associated with immune deficiencies. Morphological problems].

  1975cites this paper
• A prospective study of the effects of weekly oral methotrexate on liver biopsy

  1975cites this paper
• Immunosuppressive and cytotoxic chemotherapy: long-term complications.

  1975cites this paper
• Non-oncogenic sequelae of cancer chemotherapy.

  1975cites this paper
• PROGNOSIS AFTER ACUTE LYMPHOBLASTIC LEUKAEMIA

  1975cites this paper
• Immunosuppressive and cytotoxic drugs in dermatology.

  1974cites this paper
• Chemotherapy of reticuloendotheliosis: Comparison of methotrexate plus prednisone vs. vincristine plus prednisone

  1974cites this paper
• Treatment of Psoriasis with Azathioprine

  1974cites this paper